| Identification | Back Directory | [Name]
5-(3-Bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one | [CAS]
768404-03-1 | [Synonyms]
5-BDBD 5-(3-Bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one 2H-Benzofuro[3,2-e]-1,4-diazepin-2-one, 5-(3-bromophenyl)-1,3-dihydro- | [Molecular Formula]
C17H11BrN2O2 | [MDL Number]
MFCD18086878 | [MOL File]
768404-03-1.mol | [Molecular Weight]
355.19 |
| Chemical Properties | Back Directory | [storage temp. ]
2-8°C | [solubility ]
DMSO: soluble15mg/mL (clear solution) | [form ]
powder | [color ]
white to beige | [InChI]
InChI=1S/C17H11BrN2O2/c18-11-5-3-4-10(8-11)15-17-16(20-14(21)9-19-15)12-6-1-2-7-13(12)22-17/h1-8H,9H2,(H,20,21) | [InChIKey]
NKYMVQPXXTZHSF-UHFFFAOYSA-N | [SMILES]
N1=C(C2=CC=CC(Br)=C2)C2OC3=CC=CC=C3C=2NC(=O)C1 |
| Hazard Information | Back Directory | [Uses]
5-BDBD is a potent P2X4 receptor antagonist. | [Biochem/physiol Actions]
5-BDBD is a specific inhibitor of P2X4. The compound inhibits P2X4 currents in CHO cells with an IC50 of 500 nM. | [in vivo]
5-BDBD (28 mg/kg; i.p.; daily for 9 days) can completely blocke the basal hyperalgesia induced by recurrent NTG injection[2]. | Animal Model: | Male C57BL/6 mice[2] | | Dosage: | 28 mg/kg | | Administration: | I.p.; daily for 9 days | | Result: | Prevented NTG-induced mechanical hypersensitivity.
|
| [IC 50]
P2X4 Receptor | [storage]
Store at RT |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Website: |
https://www.sigmaaldrich.cn |
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|